Score Breakdown
Offering Ability
60
Cash Runway
10
Float Risk
50
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 10%
💰 Capital Raise
model 20%
• Active shelf registration ($125M, 15% of market cap)
Market Data
Market Cap$836.71M
Shares Outstanding36.29M
Float19.96M
Cash$200.79M
DebtN/A
Short InterestN/A
Institutional Holdings
QoQ: ↑ 33.8% shares (2026Q1 vs prior)
84 institutional holders · 36.64M shares
#1
EQT Fund Management S.a r.l.
4.93M shares
#2
RA CAPITAL MANAGEMENT, L.P.
3.49M shares
#3
Pivotal bioVenture Partners Investment Advisor LLC
1.93M shares
+ 17 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest4.48M
Days to Cover8.7
% of Float22.5%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2025-12-31
EFFECT
EFFECT
2026-04-24
424B3
ATM
2026-04-24
S-1
SHELF
2026-04-17
4
INSIDER TRANSACTION
2026-04-17
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual EVMN Dilution Snapshot
Evommune, Inc. (EVMN) has a DilutionScore of 53/100, rated High dilution risk. Score date: August 28, 2026.
- Stored shelf registration capacity: $125.0M.
- Recent SEC activity tracked for EVMN: EFFECT on 2026-04-24; 424B3 on 2026-04-24; S-1 on 2026-04-17.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: